Willrich et al. found that the CYP3A5*3A allele was associated with reduced cholesterol-lowering response to ATV in 139 non-African individuals with hypercholesterolemia (Willrich et al., 2008). The gene discussed is CYP3A5; the disease is Hypercholesterolemia.